Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
02/2010
02/17/2010EP2152270A1 Piperidine/piperazine derivatives
02/17/2010EP2152268A1 Method of treating diabetes
02/17/2010EP2152252A2 Selective proteasome inhibitors for treating diabetes
02/17/2010EP1809125B1 Nutrition containing fat blend
02/17/2010EP1581215B1 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes
02/17/2010EP1511737B1 Aryloximes
02/17/2010CN101648949A inhibitors of phosphatidylinositol 3-kinase
02/17/2010CN100590196C Branched neutral amino acid transporters acting as single molecule
02/16/2010US7662933 Pegylated granulocyte colony stimulating factor (G-CSF) to treat a hematopoietic disorder related to reduced neutrophil count, such as infectious disease, sepsis, or a result of radiotherapy or chemotherapy
02/16/2010US7662854 HIF hydroxylase inhibitors
02/16/2010US7662843 Isoxazoline compounds having MIF antagonist activity
02/16/2010US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma
02/16/2010US7662819 Pteridinone derivatives for use as stearoyl CoA desaturase inhibitors
02/16/2010US7662817 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome
02/16/2010US7662814 4-(4-Ethylpiperazin-1-yl)-5-methyl-2-phenylthieno[2,3-d]pyrimidine-6-carbonitrile; asthma, atopic dermatitis, chronic obstructive pulmonary disease, Crohn's disease, type I and type II diabetes, lymphoid leukemia and other forms of cancer, multiple sclerosis and autoimmune diseases
02/16/2010US7662799 Powder of amino acids and method for producing the same
02/16/2010US7662775 Method for screening agents for the treatment of diabetes
02/16/2010US7662768 Transdifferentiation of pancreatic acinar cells
02/16/2010US7662633 Method of screening for inhibitors of osteopontin
02/16/2010US7662392 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function
02/16/2010US7662366 Administering granulocyte colony stimulating factor; treating type 2 diabetes in simple, safe manner
02/16/2010CA2556175C Calcium formate for use as a phosphorus binder and a dietary supplement
02/16/2010CA2479274C Thiazolidinedione derivatives and pharmaceutical composition comprising the same
02/16/2010CA2478183C Substituted amides
02/16/2010CA2450922C Piperidines for use as orexin receptor antagonists
02/16/2010CA2440037C Benzimidazole derivatives for modulating the rage receptor
02/16/2010CA2438961C Beta-lactam compounds, manufacturing methods of the compounds and serum hypocholesterolemic agents containing the compounds
02/16/2010CA2402436C Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
02/16/2010CA2346082C Tricyclic .delta.3-piperidines as pharmaceuticals
02/11/2010WO2010017323A1 Novel methylenedioxy phenolic compounds and their use to treat disease
02/11/2010WO2010017260A1 Tripyridyl carboxamide orexin receptor antagonists
02/11/2010WO2010017154A2 Modulation of toll-like receptor 3 expression by antisense oligonucleotides
02/11/2010WO2010017055A2 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
02/11/2010WO2010016846A1 Heterocyclic modulators of tgr5 for treatment of disease
02/11/2010WO2010016590A1 Therapeutic or prophylactic agent for generalized pain syndrome
02/11/2010WO2010016549A1 Tricyclic compound
02/11/2010WO2010015664A1 Treatment for diabetes in patients inappropriate for metformin therapy
02/11/2010WO2010015657A2 New alkoxypyrazoles
02/11/2010WO2010015656A2 New alkoxypyrazoles
02/11/2010WO2010015212A1 COMPOUND WITH AGITATION EFFECT ON PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ, AND PREPARATION METHOD AND USE THEREOF
02/11/2010WO2010015032A1 Methods of treating and preventing glucose toxicity
02/11/2010WO2009141532A3 Derivatives of 1,5-diphenyl pyrrole-3-carboxamide, preparation thereof and use of same as cannabinoid cb1 receptor antagonists
02/11/2010WO2009138386A3 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
02/11/2010WO2009053652A3 Pharmaceutical or dietetic composition comprising an aqueous extract of nigella sativa
02/11/2010US20100035990 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar)
02/11/2010US20100035962 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with cyclohexyl groups, method for producing the same, drugs containing said compounds and use thereof
02/11/2010US20100035961 Novel 1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof
02/11/2010US20100035956 Compounds Having CRTH2 Antagonist Activity
02/11/2010US20100035953 Pyrazole Phenyl Derivatives
02/11/2010US20100035934 Pyridinyl-pyrazole derivatives and their use as potassium channel modulators
02/11/2010US20100035931 Tripyridyl carboxamide orexin receptor antagonists
02/11/2010US20100035929 Unnatural dispyrin analogues, preparation and uses thereof
02/11/2010US20100035915 Indolizine derivatives and the use thereof as antidiabetics
02/11/2010US20100035909 Novel substituted diaza-spiro-pyridinone derivatives for use in mch-1 mediated diseases
02/11/2010US20100035907 New 2,4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
02/11/2010US20100035903 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases
02/11/2010US20100035897 Pyridine, pyrimidine and pyrazine derivatives as gpcr agonists
02/11/2010US20100035893 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof
02/11/2010US20100035891 Pharmaceutically Active Compounds
02/11/2010US20100035886 Parenteral formulations of dopamine agonists
02/11/2010US20100035871 Benzoxazine derivatives and uses thereof
02/11/2010US20100035870 Pyrimidin-4-yl-3, 4-Dihydro-2H-Pyrrolo[1,2A] Pyrazin-1-one Compounds
02/11/2010US20100035864 2,2-Dimethyl-4-oxo-4-(4-{4-[(2-phenyl-5-trifluoromethyl-oxazole-4-carbonyl)-amino]-phenyl}-[1,4]diazepan-1-yl)-butyric acid, hydrochloride; obesity, type II diabetes mellitus and metabolic syndrome
02/11/2010US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof
02/11/2010US20100035834 Novel 1,4-benzothiepin-1, 1-dioxide derivatives with improved properties method for producing the same, drugs containing said compounds and the use thereof
02/11/2010US20100035795 Use of ultrarapid acting insulin
02/11/2010US20100035794 Use of ultrarapid acting insulin
02/11/2010US20100034885 Formulations containing glimepiride and/or its salts
02/11/2010US20100034866 Fused stem cells useful for the treatment of diabetes and methods thereof
02/11/2010US20100034860 Intra-Oral Device for Treating Obesity
02/11/2010US20100034823 Crystalline anti-hTNFalpha antibodies
02/11/2010US20100034816 Treatment of Diabetes by at Least One Epidermal Growth Factor Receptor Specific Antibody or a Derivative Thereof
02/11/2010CA2733430A1 Novel methylenedioxy phenolic compounds and their use to treat disease
02/11/2010CA2733006A1 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal
02/11/2010CA2733005A1 Truncated analogues of glucose-dependent insulinotropic polypeptide
02/11/2010CA2732973A1 Glucose-dependent insulinotropic polypeptide analogues
02/11/2010CA2732949A1 Analogues of glucose-dependent insulinotropic polypeptide
02/11/2010CA2732803A1 Treatment for diabetes in patients inappropriate for metformin therapy
02/11/2010CA2732797A1 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
02/11/2010CA2732682A1 Tripyridyl carboxamide orexin receptor antagonists
02/11/2010CA2732165A1 Therapeutic agents 414
02/11/2010CA2731897A1 Diazepine and diazocane compounds as mc4 agonists
02/10/2010EP2151500A1 Branched -glucan, -glucosyltransferase producing the same, method for producing the same and use thereof
02/10/2010EP2151454A2 Platelet-derived growth factor D, DNA coding therefor, and uses thereof
02/10/2010EP2151440A1 Heterocyclic compound and use thereof
02/10/2010EP2151436A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity
02/10/2010EP2151434A1 Alkoxypyrazoles and the process for their preparation
02/10/2010EP2151433A1 Alkoxypyrazoles and the process for their preparation
02/10/2010EP2151236A1 G-protein-conjugated receptor agonist
02/10/2010EP1833805B1 New 3-phenylpropionic acid derivatives for the treatment of diabetes
02/10/2010EP1490365B1 Azaindoles as inhibitors of c-jun n-terminal kinases
02/10/2010CN100588647C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
02/09/2010US7659407 Pharmaceutical compounds
02/09/2010US7659311 Delivery of agents such as heparin and calcitonin; greater efficacy; disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
02/09/2010US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders
02/09/2010US7659269 Substituted indolealkanoic acids
02/09/2010CA2557576C Novel benzothiazepine and benzothiepine compounds
02/09/2010CA2471265C Pyrimidotriazines as phosphatase inhibitors
02/09/2010CA2439593C Heterocyclic compounds for aging-related and diabetic vascular complications
02/09/2010CA2437505C Isoxazoline derivatives as anti-depressants